Illustration showing how regulatory debt in medical device development accumulates beneath compliance processes

Regulatory Debt. What it is and Why It Always Comes Due at the Worst Possible Moment?

CE, EU MDR, FDA, QMS, Regulatory, Uncategorized

Regulatory debt in medical device development I think you have heard the word “Technical debt”. It is “a qualitative description of the cost to maintain a system that is attributable to choosing an expedient solution for its development.” The term technical debt was coined by Ward Cunningham in 1992 but after that it has been revised, with the main highlight being […]

Regulatory Debt. What it is and Why It Always Comes Due at the Worst Possible Moment? Read More »

MedTech regulatory documentation with post-it notes showing questions about EU MDR, FDA, device classification, QMS and regulatory timelines.

The Three Strategic Headaches of a MedTech Startup Founder and How to Solve Them Early

CE, EU MDR, FDA, IVDR, QMS, Uncategorized

Medtech startup regulatory strategy often determines the outcome of the race between innovation and regulation. For a founder, the reality is like trying to run fast while assembling the track underneath you. The pressure isn’t just about building a great product. It’s about making decisions early that quietly determine whether the company can ever sell

The Three Strategic Headaches of a MedTech Startup Founder and How to Solve Them Early Read More »